Ranokhon Igamberdieva

30 ta ish

Tashkent pediatric medical institute, Internal medicine, Tashkent, Uzbekistan

1. P0213CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: RISK OF COMPLICATIONS

   Sherzod Abdullaev, Ranokhon Igamberdieva

   MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20200 iqtibos

   ABIABI:AkademIndex/openalex/2020.article.002654

2. Epidemiological, clinical and morphological aspects of kidney damage in COVID-19

   Batir Daminov, Sherzod Abdullaev, Olimkhon Sharapov +1

   MaqolaCOVID-19 Clinical Research StudiesJournal of Renal Injury Prevention20210 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.001967

3. MO123USE OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE*

   Sherzod Abdullaev, Ranokhon Igamberdieva, Olimkhon Sharapov

   MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20210 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.002955

4. POS-358 ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE IN COMBINATION WITH ATRIAL FIBRILLATION

   Ranokhon Igamberdieva, Sherzod Abdullaev, Olimkhon Sharapov

   MaqolaNeurological Disorders and TreatmentsKidney International Reports20210 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.004689

5. MO184ANTICOAGULANT THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION

   Sherzod Abdullaev, Ranokhon Igamberdieva, Olimkhon Sharapov

   MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20210 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.006221

6. MO182: Safety Analysis of Anticoagulant Therapy in Stage 4 CKD in Combination with AF

   Ranokhon Igamberdieva, Sherzod Abdullaev

   MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.002165

7. POS-246 EVALUATION OF THE USE OF RIVAROXABAN IN PATIENTS WITH STAGE 4 CKD IN AF

   Ranokhon Igamberdieva, Sherzod Abdullaev

   MaqolaAtrial Fibrillation Management and OutcomesKidney International Reports20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.002924

8. POS-320 EFFECTIVENESS AND SAFETY OF RIVAROXABAN VERSUS WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH OBESITY, TYPE TWO DIABETES AND CKD

   Sherzod Abdullaev, Ranokhon Igamberdieva

   MaqolaAtrial Fibrillation Management and OutcomesKidney International Reports20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.002970

9. MO638: Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Obesity, Type Two Diabetes, CKD

   Sherzod Abdullaev, Ranokhon Igamberdieva

   MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.004913

10. MO162: Renal Function During Long-Term Use of Oral Anticoagulants in Patients with Atrial Fibrillation

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos

    ABIABI:AkademIndex/openalex/2022.article.004975

11. MO143: Dynamics of Renal Function during Anticoagulant Therapy in Stage 4 CKD and AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 iqtibos

    ABIABI:AkademIndex/openalex/2022.article.004978

12. Oral anticoagulation in end-stage CKD and atrial fibrillation

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaAtrial Fibrillation Management and OutcomesInternational Journal of Health Sciences20220 iqtibos

    ABIABI:AkademIndex/openalex/2022.article.007035

13. #3055 ASSOCIATION OF MORTALITY WITH INTRADIALYTIC EXERCISE IN HEMODIALYSIS PATIENTS

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaDialysis and Renal Disease ManagementNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/openalex/2023.article.002567

14. #3896 SAFETY OUTCOMES OF ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/openalex/2023.article.003120

15. #2765 EVALUATION OF ANTIBODY RESPONSES TO SARS-COV-2 VACCINES IN PATIENTS WITH CKD

    Sherzod Abdullaev, Olimkhon Sharapov, Ranokhon Igamberdieva

    MaqolaSARS-CoV-2 and COVID-19 ResearchNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/openalex/2023.article.008409

16. #3897 STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF THE HEART IN ELDERLY AND OLD PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaHealthcare Systems and Public HealthNephrology Dialysis Transplantation20230 iqtibos

    ABIABI:AkademIndex/openalex/2023.article.008418

17. #1912 Assessment of the dynamics of renal anemia in patients with atrial fibrillation and chronic kidney disease stage IIIb-V during anticoagulant therapy

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaHealthcare Systems and Public HealthNephrology Dialysis Transplantation20240 iqtibos

    ABIABI:AkademIndex/openalex/2024.article.003483

18. #2562 Effect of rituximab on post-transplant outcome in highly sensitized patients

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaRenal Transplantation Outcomes and TreatmentsNephrology Dialysis Transplantation20240 iqtibos

    ABIABI:AkademIndex/openalex/2024.article.006258

19. #1986 Incidence of renal anemia among patients with atrial fibrillation and chronic kidney disease stage IIIb-V

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20240 iqtibos

    ABIABI:AkademIndex/openalex/2024.article.006263

20. #1994 Analysis of dynamics of parameters of safety and effectiveness of rivaroxaban in patients with stage IV chronic kidney disease and atrial fibrillation

    Ranokhon Igamberdieva, Sherzod Abdullaev

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20240 iqtibos

    ABIABI:AkademIndex/openalex/2024.article.006267

21. #377 Assessment of kidney function by creatinine and cystatin C and cardiovascular outcomes in patients with atrial fibrillation

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaBlood Pressure and Hypertension StudiesNephrology Dialysis Transplantation20240 iqtibos

    ABIABI:AkademIndex/openalex/2024.article.006281

22. #206 The effect of dapagliflozin on anemia in patients with CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaDiabetes Treatment and ManagementNephrology Dialysis Transplantation20240 iqtibos

    ABIABI:AkademIndex/openalex/2024.article.006290

23. WCN25-3811 PROGRESSION OF ANTICOAGULANT-RELATED NEPHROPATHY AFTER ANTICOAGULANT THERAPY

    Sherzod Abdullaev, Ranokhon Igamberdieva

    MaqolaAmyloidosis: Diagnosis, Treatment, OutcomesKidney International Reports20250 iqtibos

    ABIABI:AkademIndex/openalex/2025.article.003425

24. #1825 Monitoring of atrial indicators in patients with chronic kidney disease and atrial fibrillation after radio-frequency ablation

    Ranokhon Igamberdieva, Sherzod Abdullaev, Музаффар Илхомжон Асомов

    MaqolaAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20250 iqtibos

    ABIABI:AkademIndex/openalex/2025.article.009272

25. #2598 Impact of empagliflozin on metabolic profile, anthropometric indices, and renal function in chronic kidney disease patients with non-alcoholic fatty liver disease

    Rakhimjon Tursunbayev, Sherzod Abdullaev, Музаффар Илхомжон Асомов +1

    MaqolaLiver Disease Diagnosis and TreatmentNephrology Dialysis Transplantation20250 iqtibos

    ABIABI:AkademIndex/openalex/2025.article.009281